Home › Funds › FARALLON CAPITAL MANAGEMENT, L.L.C. › RVMD

FARALLON CAPITAL MANAGEMENT, L.L.C. position in RVMD

REVOLUTION MEDICINES INC · Health Care

FARALLON CAPITAL MANAGEMENT, L.L.C. reported holding 13,550,796 shares of RVMD (REVOLUTION MEDICINES INC) in its Q2 2026 13F filing — a position valued at US$2.54B, representing 11.78% of its reported portfolio and ranking #2 among its reported holdings. FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)13.55M sh
Reported value held$2.54B
Portfolio Weight11.78%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How FARALLON CAPITAL MANAGEMENT, L.L.C.'s RVMD position evolved

FARALLON CAPITAL MANAGEMENT, L.L.C. first disclosed a stake in RVMD in Q3 2023 at 3,325,480 shares (US$92.0M). The position peaked in Q2 2026 at 13,550,796 shares, worth US$2.54B. Across 12 filings, FARALLON CAPITAL MANAGEMENT, L.L.C. increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 13,550,796 shares valued at US$2.54B. Notable position changes include a 103% increase in Q4 2023 (shares rose 12% over the following quarter), a 30% increase in Q2 2024 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.33M $92.05M New
Q4 2023 6.74M $193.21M Add
Q1 2024 7.51M $241.98M Add
Q2 2024 9.76M $378.70M Add
Q3 2024 11.32M $513.26M Add
Q4 2024 13.25M $579.50M Add
Q1 2025 13.53M $478.59M Add
Q2 2025 14.33M $527.04M Add
Q3 2025 14.63M $683.02M Add
Q4 2025 14.58M $1.16B Hold
Q1 2026 13.60M $1.32B Reduce
Q2 2026 13.55M $2.54B Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RVMD and 13F data

RVMD (REVOLUTION MEDICINES INC) is a Health Care company. 60 other funds we track also report a position in RVMD — the largest reported positions include Farallon Capital Management (US$2.54B), BAKER BROS. ADVISORS LP (US$2.14B), Darwin Global Management, Ltd. (US$2.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RVMD

All RVMD fund holders →

FAQ

How long has FARALLON CAPITAL MANAGEMENT, L.L.C. held RVMD?

FARALLON CAPITAL MANAGEMENT, L.L.C. has disclosed RVMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is FARALLON CAPITAL MANAGEMENT, L.L.C.'s current position in RVMD?

As of Q2 2026, FARALLON CAPITAL MANAGEMENT, L.L.C. holds 13.55M shares of RVMD (REVOLUTION MEDICINES INC), valued at $2.54B, representing 11.78% of its reported portfolio and ranking #2.

Has FARALLON CAPITAL MANAGEMENT, L.L.C. been buying or selling RVMD?

In the latest 13F filing (Q2 2026), FARALLON CAPITAL MANAGEMENT, L.L.C. held unchanged its position in RVMD. The position peaked in Q2 2026 at 13.55M shares.

Which other funds hold RVMD?

Other major institutional holders of RVMD include Farallon Capital Management, BAKER BROS. ADVISORS LP, Darwin Global Management, Ltd., among 60 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.